Within the Chaperon action, the Laboratory of Translational Cancer Genomics was established at the Biomedical Center and is led by the ERA Chair holder Kari Hemminki, employing a newly established team of excellent researchers (see Lab members). The precise research focus is on of the following topics:
- patient-oriented cancer genomics
- genomic factors in tumorigenesis and epithelial-mesenchymal transition
- hereditary cancer genomics and epidemiology
- application of advanced genomics methods in clinical screening and decision-making
- targeted treatment based on mutations in tumors following the precision medicine guidelines
Lab members
| Researchers | Technical support |
| Prof. Kari Hemminki, M.D., Ph.D. | Jana Gallová |
| Filip Ambrozkiewicz, Ph.D. (genetics) | Ing. Lucie Musilová |
| Andriy Trailin, MD, DSc (pathology) | Bc. Jan Javůrek |
| Phanindra Babu Kasi, Ph.D. (biochemistry) | |
| MVDr. Lenka Cervenkova (pathology) | Jana Dosoudilová |
| Sergii Pavlov, Ph.D. (pathology) | Gabriela Suchá |
| Dattatrya Shetti, Ph.D. (genomics) | |
| Esraa Sobhe Abdelhamid Mahmoud, B.Sc., M.Sc. (pathology) | |
| Mgr. Marie Rajtmajerová (genomics) | |
| Venkata Ramana Mallela, MSc. B-Pharm. (genomics) | |
| Wenjing Ye, MD (genomics) | |
| Doc. MUDr. Ondrej Fiala, Ph.D. (oncology) | |
| MUDr. Ludmila Vodickova, CSc. (genomics) | |
| MUDr. Pavel Vodicka, CSc. (genomics) |